SCHEMBL5015136

SCHEMBL5015136

CCOC(=O)C(C)(C)C(=O)OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.54
PKM P14618 3/20 0.44
MMP8 P22894 2/20 0.44
MGAM O43451 1/20 0.44
GAA P10253 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP4F2 P78329 3/20 0.42
CYP4A11 Q02928 3/20 0.42
THRB P10828 1/20 0.42
ALDH1A1 P00352 2/20 0.42
HTT P42858 1/20 0.41
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALOX15 P16050 1/20 0.39
SOAT1 P35610 1/20 0.39
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5453463 0.98 DGAT1 (0.52) DGAT1PKMMMP8MGAMGAA
SCHEMBL1562023 0.90 ALDH1A1 (0.50) PKMMMP8MGAMGAASI
Hydrochloric Acid SCHEMBL5446995 0.87 ALDH1A1 (0.48) PKMMMP8MGAMGAASI
Butane SCHEMBL11358505 0.85 ALDH1A1 (0.46) PKMMMP8MGAMGAASI
SCHEMBL808799 0.82 DGAT1 (0.74) DGAT1MGAMGAASIMGAM2
SCHEMBL10949469 0.79 PKM (0.43) DGAT1PKMMMP8MGAMGAA
SCHEMBL28176663 0.79 PKM (0.43) DGAT1PKMMMP8MGAMGAA
SCHEMBL2597354 0.79 CYP4F2 (0.41) PKMMMP8MGAMGAASI
SCHEMBL10817958 0.79 DGAT1 (0.52) DGAT1
SCHEMBL23091415 0.79 DGAT1 (0.70) DGAT1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377615-B1 METHOD FOR CONTROLLED FREE RADICAL POLYMERISATION OF ACRYLIC ACID AND SALTS THEREOF, RESULTING LOW-POLYDISPERSITY POLYMERS, AND THEIR USES COATEX SAS (FR) 2009-06-24 EP disclosed
US-7436651-B2 Electric double layer capacitor and electrolytic solution therefor MITSUBISHI CHEMICAL CORPORATION (JP) 2008-10-14 US disclosed
US-20070191395-A1 Heterocyclic compounds having antifungal activity DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-08-16 US disclosed
US-20070002522-A1 Electric double layer capacitor and electrolytic solution therefor MITSUBISHI CHEMICAL CORPORATION (JP) 2007-01-04 US disclosed
EP-1717238-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191395-A1 Heterocyclic compounds having antifungal activity ERG28, MANBA, MAN2B1 DGAT1 1554/4885PKM 1249/4885MMP8 711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.